Canary Submits Site Evidence Package to Health Canada Pursuant to Cannabis License Application

May 14th 2019

Canary Rx Inc. (“Canary” or the “Company”) is pleased to announce the submission of a Site Evidence Package to Health Canada pursuant to its Cultivation, Processing and Sales License application under the Cannabis Act.

The Site Evidence Package demonstrates to Health Canada that Canary’s facility is complete, compliant and operationally ready. Submission marks the final step in Canary’s bid to obtain a license to cultivate cannabis at the Company’s Norfolk County production facility. Completion of the Site Evidence Package represents a significant development towards Canary’s ambition to produce small-batch, premium, organic cannabis.

“The Canary team is delighted to have accomplished the final step in our application process”, said Randall McLeod, CEO and President of Canary. “This milestone has been a long time coming, and we’re eager to commence operations”.

Canary’s Site Evidence Package was prepared by Jeff Hannah, Director of Consulting Services at the industry leading firm, 3 Sixty Secure Corp. Jeff Hannah has supported Canary with his expert regulatory security compliance services throughout the licensing application process.

“I’m very impressed by the Canary facility and especially the team of professionals who worked to design and build it. The project was a great collaborative effort. I’m proud of the work that 3 Sixty Secure was able to do on the security aspects of the project and I look forward to continuing to support them”.

See Press Release